JAMA

September 17, 2020

Study finds COVID-19 antibodies drop substantially in the weeks following infection

The antibody levels to SAR-CoV-2, the virus that causes COVID-19, substantially drop in the weeks following infection, according to a study led by Vanderbilt University Medical Center and the Centers for Disease Control and Prevention (CDC).

By Nancy Humphrey
January 23, 2020

Study examines prostate cancer treatment decisions

A five-year follow-up study of more than 2,000 U.S. men who received prostate cancer treatment is creating a road map for future patients regarding long-term bowel, bladder and sexual function in order to clarify expectations and enable men to make informed choices about care.

By Craig Boerner
October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

By Paul Govern
August 20, 2019

Quitting smoking associated with lower risk of cardiovascular disease

A new Vanderbilt study documents the great incentive for current smokers to quit.

By Matt Batcheldor
January 29, 2019

Long-term unemployment linked to increase in babies born with drug withdrawal

Babies born after being exposed to opioids before birth are more likely to be delivered in regions of the U.S. with high rates of long-term unemployment and lower levels of mental health services, according to a study from researchers at Vanderbilt University Medical Center and the RAND Corporation.

By Holly Fletcher
x-ray of stomach
December 4, 2018

Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk

A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.

By Jill Clendening
August 14, 2018

Medically underserved women in the Southeast rarely receive BRCA tests

Medically underserved women in the Southeast diagnosed with breast cancer or ovarian cancer missed out on genetic testing that could have helped them and their relatives make important decisions about their health, according to new research from Vanderbilt-Ingram Cancer Center.
By Tom Wilemon
February 15, 2018

Sepsis trial ranked No. 1 on critical care website

A clinical trial of an intervention for sepsis in patients in Zambia, led by Vanderbilt investigators, topped the list of 2017 trials featured by the website The Bottom Line.
By Leigh MacMillan
August 17, 2017

Study questions fees of medical specialty boards

Physicians have been objecting to the high cost of the certification fees of the American Board of Medical Specialties (ABMS) member boards for many years, and a research letter published recently by the Journal of the American Medical Association (JAMA) shows that the revenue of these boards greatly exceeded expenditures in 2013.
By Jill Clendening
March 21, 2017

Study shows active surveillance preserves quality of life for prostate cancer patients

Faced with the negative quality-of-life effects from surgery and radiation treatments for prostate cancer, low risk patients may instead want to consider active surveillance with their physician, according to a study released Tuesday by the Journal of the American Medical Association (JAMA).
By Craig Boerner
June 14, 2016

Study shows opioids increase risk of death when compared to other pain treatments

Long-acting opioids are associated with a significantly increased risk of death when compared with alternative medications for moderate-to-severe chronic pain, according to a Vanderbilt study released today in the Journal of the American Medical Assocation (JAMA).
By Craig Boerner
February 23, 2016

VUMC study finds statins do not ease kidney injury following cardiac surgery

By Paul Govern
January 5, 2016

Vanderbilt study raises questions about reporting incidental genetic findings

A genetic test that suggests a patient may be at increased risk for potentially fatal heart rhythms is very often not as ominous as it sounds.
By Bill Snyder
1 2 3 4